BACKGROUND: Prior evidence suggests a link between inflammation and hypertension. Interleukin-6 (IL-6) has been implicated in animal studies to play an important role in angiotensin II (ANGII)-mediated hypertension. The aim of this study was to examine the relationship of IL-6 and renin-angiotensin system (RAS) activity in human hypertension. METHODS: Data from 385 hypertensives and 196 normotensives are included in this report. Blood pressure and laboratory evaluation were performed on liberal and low sodium diets. IL-6 response to an ANGII infusion was evaluated to assess the effect of acute RAS activation. RESULTS: Hypertensives had higher baseline IL-6 and C-reactive protein (CRP) compared with normotensives on both diets. IL-6 increased in response to ANGII in hypertensives and normotensives (28% in hypertensives, 31% in normotensives, P ≤ 0.001 for change from baseline). In the setting of RAS activation by a low salt diet, multivariate regression analysis adjusted for age, body mass index (BMI), gender, race, and hypertension status demonstrated an independent positive association of plasma renin activity (PRA) with CRP (β = 0.199, P < 0.001). There was no significant difference in IL-6 or CRP levels between liberal and low sodium diets. CONCLUSION: These findings confirm an association between hypertension and inflammation and provide human data supporting previous evidence from animal studies that IL-6 plays a role in ANGII-mediated hypertension. Notably, compared to levels on a liberal sodium diet, neither IL-6 nor CRP were higher with activation of the RAS by a low salt diet indicating that a low sodium diet is not inflammatory despite increased RAS activity.
BACKGROUND: Prior evidence suggests a link between inflammation and hypertension. Interleukin-6 (IL-6) has been implicated in animal studies to play an important role in angiotensin II (ANGII)-mediated hypertension. The aim of this study was to examine the relationship of IL-6 and renin-angiotensin system (RAS) activity in humanhypertension. METHODS: Data from 385 hypertensives and 196 normotensives are included in this report. Blood pressure and laboratory evaluation were performed on liberal and low sodium diets. IL-6 response to an ANGII infusion was evaluated to assess the effect of acute RAS activation. RESULTS:Hypertensives had higher baseline IL-6 and C-reactive protein (CRP) compared with normotensives on both diets. IL-6 increased in response to ANGII in hypertensives and normotensives (28% in hypertensives, 31% in normotensives, P ≤ 0.001 for change from baseline). In the setting of RAS activation by a low salt diet, multivariate regression analysis adjusted for age, body mass index (BMI), gender, race, and hypertension status demonstrated an independent positive association of plasma renin activity (PRA) with CRP (β = 0.199, P < 0.001). There was no significant difference in IL-6 or CRP levels between liberal and low sodium diets. CONCLUSION: These findings confirm an association between hypertension and inflammation and provide human data supporting previous evidence from animal studies that IL-6 plays a role in ANGII-mediated hypertension. Notably, compared to levels on a liberal sodium diet, neither IL-6 nor CRP were higher with activation of the RAS by a low salt diet indicating that a low sodium diet is not inflammatory despite increased RAS activity.
Authors: Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi Journal: Hypertension Date: 2010-10-04 Impact factor: 10.190
Authors: Bindu Chamarthi; Nikheel S Kolatkar; Steven C Hunt; Jonathan S Williams; Ellen W Seely; Nancy J Brown; Laine J Murphey; Xavier Jeunemaitre; Gordon H Williams Journal: J Clin Endocrinol Metab Date: 2007-01-30 Impact factor: 5.958
Authors: LaShon C Sturgis; Joseph G Cannon; Derek A Schreihofer; Michael W Brands Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-10-07 Impact factor: 3.619
Authors: Natapong Kosachunhanun; Steven C Hunt; Paul N Hopkins; Roger R Williams; Xavier Jeunemaitre; Pierre Corvol; Claudio Ferri; Richard M Mortensen; Norman K Hollenberg; Gordon H Williams Journal: Hypertension Date: 2003-10-06 Impact factor: 10.190
Authors: Shireen Hashmat; Nathan Rudemiller; Hayley Lund; Justine M Abais-Battad; Scott Van Why; David L Mattson Journal: Am J Physiol Renal Physiol Date: 2016-06-08
Authors: A Grotevendt; H Wallaschofski; M Reincke; C Adolf; M Quinkler; M Nauck; W Hoffmann; R Rettig; A Hannemann Journal: Endocrine Date: 2017-06-22 Impact factor: 3.633
Authors: Annette D de Kloet; David J Pioquinto; Dan Nguyen; Lei Wang; Justin A Smith; Helmut Hiller; Colin Sumners Journal: Physiol Behav Date: 2014-02-06
Authors: Elena Y Senchenkova; Janice Russell; Alper Yildirim; D Neil Granger; Felicity N E Gavins Journal: Hypertension Date: 2019-04 Impact factor: 10.190